News & Updates
Filter by Specialty:

Plant-based DASH diet beneficial in obese patients with metabolic syndrome
Dropping animal protein for plant proteins in the dietary approaches to stop hypertension (DASH) diet appears to have favourable effects on cardiometabolic risk factors in patients with obesity and metabolic syndrome, according to a double-blind randomized controlled clinical trial.
Plant-based DASH diet beneficial in obese patients with metabolic syndrome
26 Oct 2022
Statins show therapeutic potential in COVID-19-related acute kidney injury
COVID-19 patients with chronic statin exposure appear to be at lower risk of developing acute kidney injury (AKI) during hospitalization in addition to having reduced levels of inflammation, as reported in a study.
Statins show therapeutic potential in COVID-19-related acute kidney injury
26 Oct 2022
Tenofovir alafenamide reduces liver stiffness in CHB patients
Treatment with the nucleos(t)ide analogue (NUC) tenofovir alafenamide (TAF) for 2 years leads to improvements in liver stiffness among patients with chronic hepatitis B (CHB), including those with advanced liver fibrosis, according to a study presented at the IDWeek 2022 in Washington, DC, US.
Tenofovir alafenamide reduces liver stiffness in CHB patients
26 Oct 2022
2–3 cups of coffee daily may keep the heart healthy
Drinking 2–3 cups of coffee – be it ground, instant, or decaffeinated – daily is consistently associated with significant reductions in the risks of cardiovascular disease (CVD), coronary heart disease (CHD), congestive cardiac failure (CCF), and all-cause mortality in a new analysis of the UK Biobank study.
2–3 cups of coffee daily may keep the heart healthy
26 Oct 2022
Smell, taste dysfunction post-COVID-19: will these persist?
Olfactory and gustatory** loss/alterations are common COVID-19 symptoms, but recovery is expected in most patients within the first 3 months. However, these dysfunctions may persist in some individuals, according to a reconstructed meta-analysis from Singapore.
Smell, taste dysfunction post-COVID-19: will these persist?
26 Oct 2022
Cefepime-taniborbactam trumps meropenem for complicated UTI
Cefepime-taniborbactam (FTB) is significantly better than meropenem for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP), according to results of the Cefepime Rescue with Taniborbactam in cUTI (CERTAIN-1) study presented at the recent ID Week 2022.
Cefepime-taniborbactam trumps meropenem for complicated UTI
26 Oct 2022
Metformin not protective against older-onset IBD
The use of metformin does not appear to confer any benefits in terms of reducing the risk of older-onset inflammatory bowel disease (IBD), a study has found.
Metformin not protective against older-onset IBD
26 Oct 2022
Silymarin reduces lesions, pain in women with endometriosis
Among women suffering from endometriosis, treatment with silymarin leads to lowered interleukin (IL)-6 concentrations, smaller endometrioma lesions, and eased pain, a recent study has found.